Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 2
1998 2
1999 5
2000 15
2001 16
2002 13
2003 20
2004 9
2005 10
2006 18
2007 12
2008 16
2009 16
2010 14
2011 17
2012 28
2013 22
2014 22
2015 23
2016 17
2017 20
2018 27
2019 24
2020 24
2021 26
2022 20
2023 25
2024 15
2025 13
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advances in Genome-Engineering Strategies.
Boti MA, Athanasopoulou K, Adamopoulos PG, Sideris DC, Scorilas A. Boti MA, et al. Among authors: scorilas a. Genes (Basel). 2023 Jan 2;14(1):129. doi: 10.3390/genes14010129. Genes (Basel). 2023. PMID: 36672870 Free PMC article. Review.
CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients.
Papadimitriou MA, Pilala KM, Panoutsopoulou K, Levis P, Kotronopoulos G, Kanaki Z, Loules G, Zamanakou M, Linardoutsos D, Sideris DC, Stravodimos K, Klinakis A, Scorilas A, Avgeris M. Papadimitriou MA, et al. Among authors: scorilas a. Mol Ther Oncol. 2024 May 24;32(2):200818. doi: 10.1016/j.omton.2024.200818. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38966038 Free PMC article.
Cancer quiescence: non-coding RNAs in the spotlight.
Soureas K, Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, Avgeris M. Soureas K, et al. Among authors: scorilas a. Trends Mol Med. 2023 Oct;29(10):843-858. doi: 10.1016/j.molmed.2023.07.003. Epub 2023 Jul 27. Trends Mol Med. 2023. PMID: 37516569 Review.
Targeting kallikrein-related peptidases in prostate cancer.
Mavridis K, Avgeris M, Scorilas A. Mavridis K, et al. Among authors: scorilas a. Expert Opin Ther Targets. 2014 Apr;18(4):365-83. doi: 10.1517/14728222.2014.880693. Epub 2014 Feb 27. Expert Opin Ther Targets. 2014. PMID: 24571737 Free article. Review.
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.
Soureas K, Malandrakis P, Papadimitriou MA, Minopoulos C, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Avgeris M, Terpos E. Soureas K, et al. Among authors: scorilas a. Blood Cancer J. 2025 Mar 15;15(1):41. doi: 10.1038/s41408-025-01248-2. Blood Cancer J. 2025. PMID: 40089465 Free PMC article.
Epi-miRNAs: Modern mediators of methylation status in human cancers.
Papadimitriou MA, Panoutsopoulou K, Pilala KM, Scorilas A, Avgeris M. Papadimitriou MA, et al. Among authors: scorilas a. Wiley Interdiscip Rev RNA. 2023 Mar;14(2):e1735. doi: 10.1002/wrna.1735. Epub 2022 May 17. Wiley Interdiscip Rev RNA. 2023. PMID: 35580998 Review.
437 results